Hospice News February 2, 2022
Humana (NYSE: HUM) is reorienting the hospice segment of its Kindred At Home subsidiary as a standalone business in anticipation of a forthcoming sale. The company also pledged to boost its overall enterprise value by an additional $1 billion, though Humana is still working out the timeframe in which they expect to hit that target.
Humana in Q3 2021 completed its acquisition of the remaining 60% stake in Kindred at Home for $8.1 billion. This price tag included an equity value of $2.4 billion from its existing 40% ownership of the business. Humana initially acquired 40% ownership in 2018, with private equity firms Welsh, Carson, Anderson & Stowe and TPG Capital then holding the remaining 60%.
The company did not...
Today's Sponsors
Today's Sponsor